PRELUDE CAPITAL MANAGEMENT, LLC

Position in FOLD — AMICUS THERAPEUTICS, INC.

CIK 1387508 NEW YORK, NY

Position in FOLD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,252,737

+$4,277,082 QoQ

Shares Held

639,885

+83.1% QoQ

Ownership

0.204%

of shares outstanding

% of Portfolio

0.76%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $75,046,663 across 96 Biotechnology names. FOLD ranks #2 (12.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc.	98,849	$11,349,842
2	FOLD	AMICUS THERAPEUTICS, INC. This page	639,885	$9,252,737
3	PGEN	Precigen, Inc.	1,270,053	$4,915,105
4	APLS	Apellis Pharmaceuticals, Inc.	111,468	$4,484,357
5	ROIV	Roivant Sciences Ltd.	111,593	$3,091,126
6	PRAX	Praxis Precision Medicines, Inc.	9,064	$2,920,330
7	TERN	Terns Pharmaceuticals, Inc.	54,825	$2,890,374
8	COGT	Cogent Biosciences, Inc.	64,222	$2,471,904

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,252,737	639,885	+83.1%	Shares	Other	2026-05-15
2025-12-31	$4,975,655	349,414	+2527.2%	Shares	Other	2026-02-17
2021-09-30	$127,015	13,300	0.0%	Shares	Sole	2021-11-15
2021-06-30	$128,212	13,300	0.0%	Shares	Sole	2021-08-16
2021-03-31	$131,404	13,300	-55.2%	Shares	Other	2021-05-17
2020-12-31	$685,957	29,708	-15.3%	Shares	Other	2021-02-16
2020-09-30	$494,990	35,056	-17.8%	Shares	Other	2020-11-16
2020-06-30	$643,493	42,672	—	Shares	Other	2020-08-14
No filing history on record for this holder in this stock.